Article
Refining the Molecular Framework for Pancreatic Cancer with Single-cell and Spatial Technologies
2 Mar 2021
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) is a treatment-refractory malignancy in urgent need of a molecular framework for guiding therapeutic strategies. Bulk transcriptomic efforts over the past decade have yielded two broad consensus subtypes: classical pancreatic/epithelial versus basal-like/squamous/quasi-mesenchymal. Although this binary classification enables prognostic stratification, it does not currently...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
